These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Influence of the severity of cognitive impairment on the effect of the Gnkgo biloba extract EGb 761 in Alzheimer's disease. Le Bars PL, Velasco FM, Ferguson JM, Dessain EC, Kieser M, Hoerr R. Neuropsychobiology; 2002; 45(1):19-26. PubMed ID: 11803237 [Abstract] [Full Text] [Related]
7. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Kanowski S, Herrmann WM, Stephan K, Wierich W, Hörr R. Pharmacopsychiatry; 1996 Mar; 29(2):47-56. PubMed ID: 8741021 [Abstract] [Full Text] [Related]
17. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial. De Jesus Moreno Moreno M. Clin Ther; 2003 Jan; 25(1):178-93. PubMed ID: 12637119 [Abstract] [Full Text] [Related]
18. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg. Herrschaft H, Nacu A, Likhachev S, Sholomov I, Hoerr R, Schlaefke S. J Psychiatr Res; 2012 Jun; 46(6):716-23. PubMed ID: 22459264 [Abstract] [Full Text] [Related]